Elekta Foundation raises USD 50,000 for women with advanced-stage cervical cancer with “Ride4Rwanda” cycling challenge
CRAWLEY, UK – Today, 40 Elekta (EKTA-B.ST) employees will embark on a 500 km cycle challenge to raise awareness and funds for women with advanced-stage cervical cancer in the Gicumbi district of Rwanda on behalf of the Elekta Foundation. Together, the team of cyclists has already raised more than USD 50,000, making Ride4Rwanda the Foundation’s largest fundraising event since it was launched in early 2022.
The cyclists will depart from Elekta’s office in the UK and will arrive in Amsterdam on September 17. Each participant has raised at least USD 1,200 so far and the top fundraiser will have the opportunity to visit the Elekta Foundation’s project in Rwanda and see, firsthand, how the Foundation works with key partners to eliminate cervical cancer in Rwanda.
One Elekta colleague, Fei Yin, who is riding from the UK to the Netherlands, says: “There’s no greater motivation than supporting an extraordinary cause and contributing to a positive global impact. This initiative demonstrates our commitment to supporting cancer patients, their families, and the medical community.”
Lacy Hubbard, President of the Elekta Foundation, says: “I’m overwhelmed by the interest, energy and commitment from Elekta employees in supporting our work in Rwanda. Earlier this year, Rwanda’s Minister of Health emphasized the need for early screening and treatment to eliminate cervical cancer in the country. These are exactly the initiatives that the Foundation is committed to. So, indirectly, the Ride4Rwanda cyclists are making a significant contribution to the health of people in Africa.”
Cancer is a leading cause of death in underserved countries, where access to quality healthcare is limited and resources are scarce. The Elekta Foundation, a philanthropic organization, is committed to closing the cancer care inequity gap and uphold the right to high quality and equitable healthcare for everyone. It has been implementing a campaign for cervical cancer prevention and treatment in the Gicumbi district since September 2022.
Learn more about the Elekta Foundation on its website: www.elektafoundation.com
# # #
For further information, please contact:
Mattias Thorsson, Vice President, Head of Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Director, Media Relations
Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time
Alice Friaux, Communications & Marketing Manager, Elekta Foundation
Tel: +46 72 719 4321, e-mail: firstname.lastname@example.org
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on X (formerly Twitter).
About Elekta Foundation
The Elekta Foundation was established in February 2022 with the mission to improve access to cancer care in underserved countries. We collaborate with governments, academic institutions, and civil society to tackle inequities in cancer care. To fulfill this ambition, we focus on cervical cancer prevention and radiotherapy education. Read more on www.elektafoundation.com, LinkedIn, Instagram and X (formerly Twitter).